Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/11/2008US7341712 Synergistic effect protecting the skin against light; use for skin tanning; impregnated wipes
03/11/2008US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
03/11/2008CA2612595A1 Compositions and methods affecting heat shock protein expression for improved muscle building
03/11/2008CA2612550A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals
03/11/2008CA2559374A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals
03/11/2008CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation
03/11/2008CA2451924C Diagnostic agents for pancreatic exocrine function
03/11/2008CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
03/11/2008CA2421880C Resorcinol derivatives
03/11/2008CA2413087C Suplatast tosilate crystals
03/11/2008CA2408548C Method for the preparation of polymeric micelle via phase separation of block copolymer
03/11/2008CA2407747C Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
03/11/2008CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
03/11/2008CA2402336C Concentrated solutions of carvedilol
03/11/2008CA2396130C Preparation of irrigating solution for ocular surgery
03/11/2008CA2391647C Biomolecular complex formed between hyaluronic acid and a biomolecule
03/11/2008CA2382489C Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
03/11/2008CA2377916C Taste masked pharmaceutical liquid formulations
03/11/2008CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity
03/11/2008CA2335104C Arylalkanoylpyridazines
03/11/2008CA2331764C Polyketides and their synthesis
03/11/2008CA2310664C Substituted 2-aminoacetamides and the use thereof
03/11/2008CA2293382C Piperazine derivatives and their use as anti-inflammatory agents
03/11/2008CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity
03/11/2008CA2289756C Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
03/11/2008CA2288147C Anti-viral pyrimidine nucleoside analogues
03/11/2008CA2274954C Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
03/11/2008CA2270396C Cationic reagents for transfection
03/11/2008CA2235177C New exocellular polysaccharide produced by streptococcus thermophilus
03/11/2008CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity
03/11/2008CA2213347C Composition and method of enhancing electrotransport agent delivery
03/11/2008CA2195425C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
03/11/2008CA2192764C Integrin receptor antagonists
03/11/2008CA2150355C Process of resolving phenylpropionic acids using alpha-methylbenzylamine
03/11/2008CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
03/08/2008CA2558956A1 Diet supplement for causing weight loss
03/07/2008WO2008078424A1 Benzoxazole derivatives
03/06/2008WO2008028193A2 Colon-targeted oral formulations of cytidine analogs
03/06/2008WO2008028168A2 Serine-threonine protein kinase and parp modulators
03/06/2008WO2008028140A1 Methods and compositions for increasing patient tolerability during myocardial imaging methods
03/06/2008WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
03/06/2008WO2008028097A2 Method for skin care
03/06/2008WO2008028094A1 Compounds as cb2 cannabinoid receptor ligands
03/06/2008WO2008028093A1 Compounds as cb2 cannabinoid receptor ligands
03/06/2008WO2008028060A2 Anti-tumor compounds for inhibiting cancer growth
03/06/2008WO2008028057A2 Shikimic acid-derived compounds for inhibition and detection of aurora a-associated tumors
03/06/2008WO2008027993A2 Drug delivery systems comprising solid solutions of weakly basic drugs
03/06/2008WO2008027991A2 USE OF DPA(n-6) OILS IN INFANT FORMULA
03/06/2008WO2008027990A1 Therapeutic methods using wrn binding molecules
03/06/2008WO2008027988A2 Methods of treating estrogen-responsive conditions by orphan nuclear receptor activation
03/06/2008WO2008027958A2 Compounds and compositions for delivering active agents
03/06/2008WO2008027949A2 Thieno pyrimidine compounds
03/06/2008WO2008027945A1 Extended release gastro-retentive oral drug delivery system for valsartan
03/06/2008WO2008027932A2 Cytochrome p450 oxidase inhibitors and uses thereof
03/06/2008WO2008027880A2 Strontium-based treatment of otosclerosis
03/06/2008WO2008027855A2 Compositions and methods for modulating mtor signaling
03/06/2008WO2008027854A2 Pharmaceutical compositions comprising hgh for oral delivery
03/06/2008WO2008027839A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists
03/06/2008WO2008027837A2 Small molecule potentiator of hormonal therapy for breast cancer
03/06/2008WO2008027812A2 Imidazopyridine and imidazopyrimidine derivatives
03/06/2008WO2008027648A2 Methods and compositions for treating pathologies associated with bdnf signaling
03/06/2008WO2008027600A2 Imatinib compositions
03/06/2008WO2008027585A2 Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors
03/06/2008WO2008027584A2 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
03/06/2008WO2008027580A2 PARTICULATE β-GLUCAN COMPOSITIONS FOR REGULATING DENDRITIC CELLS
03/06/2008WO2008027557A2 Topiramate compositions and methods of enhancing its bioavailability
03/06/2008WO2008027551A2 Dendrimer compositions
03/06/2008WO2008027547A2 Antioxidant therapies
03/06/2008WO2008027542A2 5-substituted isoindoline compounds
03/06/2008WO2008027523A2 Salts of benzimidazolyl pyridyl ethers and formulations thereof
03/06/2008WO2008027521A1 Novel compositions and methods for treatment of diseases related to activated lymphocytes
03/06/2008WO2008027483A1 Benzofuran derivatives as modulators of the 5-ht2a receptor
03/06/2008WO2008027470A2 Compositions and methods of use thereof for the removal of ticks from epidermal tissue
03/06/2008WO2008027466A1 Hydantoin derivatives useful as antibacterial agents
03/06/2008WO2008027445A2 Combination with bis(thiohydrazide amides) for treating cancer
03/06/2008WO2008027419A2 Tizanidine sulfate salt forms and methods of making and using the same
03/06/2008WO2008027395A2 Pharmaceutical compositions of benzodiazepines and methods of use thereof
03/06/2008WO2008027357A2 Pharmaceutical compositions of clonazepam and methods of use thereof
03/06/2008WO2008027356A2 Compositions containing cdp-choline, and methods of use thereof
03/06/2008WO2008027345A2 COMBINED γ-SECRETASE INHIBITOR AND PHENOTHIAZINE DERIVATIVE TREATMENT OF NEURODEGENERATIVE DISEASES
03/06/2008WO2008027341A2 Topical ophthalmic formulations
03/06/2008WO2008027340A2 Topical ophthalmic formulations
03/06/2008WO2008027284A1 Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
03/06/2008WO2008027273A2 Solid citrate and tartrate salts of dpp-iv inhibitors
03/06/2008WO2008027210A2 Biocompatible stent
03/06/2008WO2008027203A2 Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
03/06/2008WO2008027182A2 Indoloquinoline compounds as calcium channel blockers
03/06/2008WO2008027081A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl] azetidin-2-one
03/06/2008WO2008027063A1 Anti-aging skin preparation
03/06/2008WO2008027055A1 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
03/06/2008WO2008027013A2 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer
03/06/2008WO2008026984A1 Topical composition comprising a dihydropyridine calcium antagonist
03/06/2008WO2008026965A1 Substituted pyrrolo[4,3-b]indoles, combinatorial and focused libraries, pharmacological composition and a method for the production and use thereof
03/06/2008WO2008026962A1 Agent for treating eye diseases
03/06/2008WO2008026937A1 Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method
03/06/2008WO2008026915A2 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
03/06/2008WO2008026907A1 Pharmaceutical composition comprising ibandronate and vitamin d3 for the treatment of osteoporosis
03/06/2008WO2008026838A1 Method for preparing an optically active amlodipine
03/06/2008WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient
03/06/2008WO2008026769A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity
1 ... 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 3365 3366 3367 3368 ... 7860